{"product_id":"harvard-advances-in-cytology","title":"Harvard Advances In Cytology And Small Biopsies 2023","description":"\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003ch2\u003e\u003cspan style=\"color: #555555; font-size: 14.4px;\"\u003eHarvard Advances In Cytology And Small Biopsies 2023 The scope of cytopathology practice has grown increasingly complex in recent years with, for example, exposure to specimen types not previously sampled using cytologic methods and the introduction of new techniques such as endoscopic ultrasound-guided fine needle aspiration.\u003c\/span\u003e\u003c\/h2\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cbr\u003e\u003cbr\u003eLarger needles used in these procedures are procuring small tissue biopsies that provide material for advanced ancillary studies that are now under the purview of the diagnostic cytopathologist. “Advances in Cytology and Small Biopsies” will provide pathologists and cytotechnologists with a comprehensive overview of and update on diagnostic pathology utilizing a combination of cytology and small biopsy specimens. The emphasis will be on the role of the cytopathologist as a multifaceted pathologist combining light microscopic criteria with ancillary testing, including immunocytochemistry, biochemical testing and genetic analysis as they apply to diagnosis, prognosis and targeted therapy.\u003cbr\u003e\u003cbr\u003eAdvances in automation and standardized terminology reporting will also be presented. The lecture format of our course is supplemented by question and answer sessions. The session at the end of each day will be an educational virtual microscopy case-based presentation focused complimentary topics and quality assurance issues applicable to all aspects of cytopathology. A syllabus of the talks will be provided in an electronic format.\u003cbr\u003e\u003cbr\u003eThe last edition of the course in 2019 was a significant update to the 29-year history of this course with HMS, including adding an emphasis on small tissue samples. Since 2019, the course has been on hiatus due to the COVID-19 pandemic. With the widespread adoption of virtual meetings, we are taking this opportunity to move to a new virtual distribution format for 2023.\u003cbr\u003e\u003cbr\u003eThe 2023 course will capitalize on the tremendous success of the revamped 2019 course, which sold out 6 weeks in advance of the course dates. The advantage of the livestream format will allow us to greatly expand the registration capacity. We will be using faculty from the three major Harvard teaching hospitals- BWH, MGH, and BIDMC and bring in a world-renowned expert- Dr. Eva Wojcik- our keynote speaker- who will discuss urinary cytopathology and changes to the most widely adopted reporting system for urinary cytopathology- The Paris System 2.0 – that was updated in 2022.\u003cbr\u003e\u003cbr\u003eWe will focus on the role of the cytopathologist in diagnosis using minimally invasive techniques and presenting updates on their role in utilizing ancillary testing for diagnosis, prognosis and targeted therapy for optimal patient care. Finally, we are updating the standardized reporting of pancreaticobiliary lesions with a brief review of the new WHO Reporting System for Pancreaticobiliary Cytology and our “Diagnostic Challenges and Lessons Learned” symposium with digitized virtual glass slides that will be available to registrants in advance of the course. Registrants will be able to submit their diagnosis prior to the case presentation at the meeting where their submissions will drive the discussion and teaching points.\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003ch3 class=\"variant-1\"\u003eWho Should Attend\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eSpecialty Physicians\u003c\/li\u003e\n\u003cli\u003ePrimary Care Physicians\u003c\/li\u003e\n\u003cli\u003eCytotechnologists\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 class=\"variant-1\"\u003eLearning Objectives\u003c\/h3\u003e\n\u003cbr\u003eUpon completion of this activity, participants will be able to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eRecognize the full range of diagnostic approaches to cytological and small tissue samples from all body sites.\u003c\/li\u003e\n\u003cli\u003eEvaluate current and potential applications of automated screening, liquid-based preparation methods, flow cytometry and molecular testing.\u003c\/li\u003e\n\u003cli\u003eAssess the impact of new technologies on cytology practice.\u003c\/li\u003e\n\u003cli\u003eApply current standards for the evaluation and work-up of cytology and small tissue samples for diagnosis, prognosis and targeted therapy.\u003c\/li\u003e\n\u003cli\u003eSummarize the new standardized terminology and reporting systems for gynecological, pancreaticobiliary, thyroid, salivary gland and urinary cytological specimens.\u003c\/li\u003e\n\u003cli\u003eIdentify diagnostic pitfalls and how to avoid them.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eDay 1 Anal Dysplasia and Anal Cancer Prevention.mp4\u003cbr\u003eDay 1 Anal Dysplasia and Anal Cancer Prevention.pdf\u003cbr\u003eDay 1 Application of Practical Informatics to Cytology.mp4\u003cbr\u003eDay 1 Application of Practical Informatics to Cytology.pdf\u003cbr\u003eDay 1 Challenging Cases and Lessons Learned – Virtual Microscopy 1.mp4\u003cbr\u003eDay 1 Challenging Cases and Lessons Learned – Virtual Microscopy 1.pdf\u003cbr\u003eDay 1 Compliance with CMS Billing.mp4\u003cbr\u003eDay 1 Compliance with CMS Billing.pdf\u003cbr\u003eDay 1 Endocervical-AGCs and Worse.mp4\u003cbr\u003eDay 1 Endocervical-AGCs and Worse.pdf\u003cbr\u003eDay 1 Endometrial Cells and Their Mimics.mp4\u003cbr\u003eDay 1 Endometrial Cells and Their Mimics.pdf\u003cbr\u003eDay 1 HSIL and Its Mimics.mp4\u003cbr\u003eDay 1 HSIL and Its Mimics.pdf\u003cbr\u003eDay 1 Primary HPV Screening and Management of Abnormal Screening Results.mp4\u003cbr\u003eDay 1 Primary HPV Screening and Management of Abnormal Screening Results.pdf\u003cbr\u003eDay 1 Questions 1.mp4\u003cbr\u003eDay 1 Questions 2.mp4\u003cbr\u003eDay 1 Questions 3.mp4\u003cbr\u003eDay 1 The Elusive Diagnosis of HSIL on the Anal Pap Test.mp4\u003cbr\u003eDay 1 The Elusive Diagnosis of HSIL on the Anal Pap Test.pdf\u003cbr\u003eDay 1 The Impact of Primary HPV Screening on the Cytology Laboratory.mp4\u003cbr\u003eDay 1 The Impact of Primary HPV Screening on the Cytology Laboratory.pdf\u003cbr\u003eDay 2 Challenging Cases and Lessons Learned – Virtual Microscopy 2.mp4\u003cbr\u003eDay 2 Challenging Cases and Lessons Learned – Virtual Microscopy 2.pdf\u003cbr\u003eDay 2 Lymph Node FNA.mp4\u003cbr\u003eDay 2 Lymph Node FNA.pdf\u003cbr\u003eDay 2 Malignant Effusions Primary versus Metastatic.mp4\u003cbr\u003eDay 2 Malignant Effusions Primary versus Metastatic.pdf\u003cbr\u003eDay 2 Molecular Testing in Cytology Specimens.mp4\u003cbr\u003eDay 2 Molecular Testing in Cytology Specimens.pdf\u003cbr\u003eDay 2 Pulmonary Cytology Workup of NSCLC on FNA and Small Biopsy.mp4\u003cbr\u003eDay 2 Pulmonary Cytology Workup of NSCLC on FNA and Small Biopsy.pdf\u003cbr\u003eDay 2 Questions 1.mp4\u003cbr\u003eDay 2 Questions 2.mp4\u003cbr\u003eDay 2 Soft Tissue FNA and Small Biopsy – Pt 1.mp4\u003cbr\u003eDay 2 Soft Tissue FNA and Small Biopsy – Pt 1.pdf\u003cbr\u003eDay 2 Soft Tissue FNA and Small Biopsy – Pt 2.mp4\u003cbr\u003eDay 2 Soft Tissue FNA and Small Biopsy – Pt 2.pdf\u003cbr\u003eDay 2 Updates In Urine Cytology Paris 2.0.mp4\u003cbr\u003eDay 2 Updates In Urine Cytology Paris 2.0.pdf\u003cbr\u003eDay 2 WHO Reporting Systems.mp4\u003cbr\u003eDay 2 WHO Reporting Systems.pdf\u003cbr\u003eDay 3 Challenges and Lessons Learned – Virtual Microscopy 3.mp4\u003cbr\u003eDay 3 Challenges and Lessons Learned – Virtual Microscopy 3.pdf\u003cbr\u003eDay 3 HPV Testing of H\u0026amp;N Squamous Cell Carcinoma.mp4\u003cbr\u003eDay 3 HPV Testing of H\u0026amp;N Squamous Cell Carcinoma.pdf\u003cbr\u003eDay 3 Molecular Testing of Thyroid FNAs.mp4\u003cbr\u003eDay 3 Molecular Testing of Thyroid FNAs.pdf\u003cbr\u003eDay 3 Non-Ductal Neoplasms of the Pancreas.mp4\u003cbr\u003eDay 3 Non-Ductal Neoplasms of the Pancreas.pdf\u003cbr\u003eDay 3 Pancreatic Cysts.mp4\u003cbr\u003eDay 3 Pancreatic Cysts.pdf\u003cbr\u003eDay 3 Pancreatic Ductal Carcinoma.mp4\u003cbr\u003eDay 3 Pancreatic Ductal Carcinoma.pdf\u003cbr\u003eDay 3 Questions 1.mp4\u003cbr\u003eDay 3 Questions 2.mp4\u003cbr\u003eDay 3 Questions 3.mp4\u003cbr\u003eDay 3 The Atypical Thyroid Aspirate.mp4\u003cbr\u003eDay 3 The Atypical Thyroid Aspirate.pdf\u003cbr\u003eDay 3 The Milan System 2.0.mp4\u003cbr\u003eDay 3 The Milan System 2.0.pdf\u003cbr\u003eDay 3 Unusual Head and Neck Tumors.mp4\u003cbr\u003eDay 3 Unusual Head and Neck Tumors.pdf\u003cbr\u003eDay 3 Updates to The Bethesda System For Reporting Thyroid Cytopathology.mp4\u003cbr\u003eDay 3 Updates to The Bethesda System For Reporting Thyroid Cytopathology.pdf\u003cbr\u003eWelcome and Introduction.mp4\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954377134178,"sku":"MED-AMB02211","price":50.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Harvard-Advances-In-Cytology-And-Small-Biopsies-2023.jpg?v=1779374913","url":"https:\/\/meducourse.com\/products\/harvard-advances-in-cytology","provider":"Meducourse","version":"1.0","type":"link"}